$Glucotrack (GCTK.US)$ 成交量巨大！将在2025年3月19日至22日于阿姆斯特丹的会议上发布其首个人体试验的连续血糖监测系统的安全性和性能数据。
已翻译
7FigsTradr
评论了
$Mill City Ventures III (MCVT.US)$ 你们看到即将发生的挤压了吗？
已翻译
2
$Impact BioMedical (IBO.US)$
留意这个。150万流通股加上内部锁定期。盘整走势在高点附近。我认为正在为更大的波动做准备。
$HCW Biologics (HCWB.US)$ $Bakkt Holdings (BKKT.US)$
留意这个。150万流通股加上内部锁定期。盘整走势在高点附近。我认为正在为更大的波动做准备。
$HCW Biologics (HCWB.US)$ $Bakkt Holdings (BKKT.US)$
已翻译
1
2
7FigsTradr
评论了
$SeaStar Medical (ICU.US)$ 2024年3月6日，纳斯达克上市公司SeaStar Medical Holding Corporation，在交易标的ICU下宣布获得纳斯达克上市资格部门的临时豁免。该豁免允许SeaStar Medical在2024年6月24日之前恢复符合纳斯达克资本市场的最低买盘价格规则，该规则要求收盘买盘价格为1.00美元
已翻译
11
4
7FigsTradr
评论了
🚨 3/12/2024 🦍的自选 via Stock_Drift
$Minim (MINM.US)$ $Aslan Pharmaceuticals (ASLN.US)$ $Trxade Health (MEDS.US)$ $Graphite Bio (GRPH.US)$ $Singularity Future Technology (SGLY.US)$ $ClearOne通讯 (CLRO.US)$
📊⚡️📊
$Minim (MINM.US)$ $Aslan Pharmaceuticals (ASLN.US)$ $Trxade Health (MEDS.US)$ $Graphite Bio (GRPH.US)$ $Singularity Future Technology (SGLY.US)$ $ClearOne通讯 (CLRO.US)$
📊⚡️📊
已翻译
3
2
$Freight Technologies (FRGT.US)$ 逐笔明细显示，最低浮动 #人工智能 逐渐积累到底部。形成较高的低点。合规新闻。
$Ocean Biomedical (OCEA.US)$ $Intuitive Machines (LUNR.US)$ $英伟达 (NVDA.US)$ $AtlasClear (ATCH.US)$ $AXT Inc (AXTI.US)$
$Ocean Biomedical (OCEA.US)$ $Intuitive Machines (LUNR.US)$ $英伟达 (NVDA.US)$ $AtlasClear (ATCH.US)$ $AXT Inc (AXTI.US)$
已翻译
3
3
7FigsTradr
评论了
$智富融资 (MEGL.US)$ $Volcon (VLCN.US)$ $MicroAlgo (MLGO.US)$ $Freight Technologies (FRGT.US)$ 本周轻松赚钱，走起！我还有几个心仪的股票。 ![]()
已翻译
1
5
![[empty]](https://static.moomoo.com/node_futunn_nnq/assets/images/folder.5c37692712.png)
![[error]](https://static.moomoo.com/node_futunn_nnq/assets/images/no-network.991ae8055c.png)
![[loading]](data:image/svg+xml;base64,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)